Luteolin: A promising natural agent in management of pain in chronic conditions
Luteolin
Overlooked Treatments
Pharmacological Activity of Eriodictyol: The Major Natural Polyphenolic Flavanone
Eriodictyol - an overview | ScienceDirect Topics
TREAT ME Survey: Individual Treatment Results
Fibrin drives thromboinflammation and neuropathology in COVID-19
Monoclonal Antibodies: A Potential Solution For Prolonged COVID Symptoms?
Remission of severe forms of long COVID following monoclonal antibody (MCA) infusions: A report of signal index cases and call for targeted research
Treatment of persistent COVID-19 in two B-cell-depleted patients with the monoclonal antibody Sotrovimab
Long COVID: Some patients may need an immune system boost
Reduced Cell Surface Levels of C-C Chemokine Receptor 5 and Immunosuppression in Long Coronavirus Disease 2019 Syndrome | Clinical Infectious Diseases | Oxford Academic
Degradative Effect of Nattokinase on Spike Protein of SARS-CoV-2
Archive - Studies, Surveys, & Supplements
Lumbrokinase, a Fibrinolytic Enzyme, Prevents Intra-Abdominal Adhesion by Inhibiting the Migrative and Adhesive Activities of Fibroblast via Attenuation of the AP-1/ICAM-1 Signaling Pathway
Patient infected with COVID-19 finally cured after 411 days
Real-Time Whole Genome Sequencing to Guide Patient-Tailored Therapy of Severe Acute Respiratory Syndrome Coronavirus 2 Infection | Clinical Infectious Diseases | Oxford Academic
Taurine deficiency as a driver of aging
Berberine reduces circulating inflammatory mediators in patients with severe COVID-19 | British Journal of Surgery | Oxford Academic
Role of SARS-CoV-2 Spike-Protein-Induced Activation of Microglia and Mast Cells in the Pathogenesis of Neuro-COVID
Early treatment with fluvoxamine, bromhexine, cyproheptadine, and niclosamide to prevent clinical deterioration in patients with symptomatic COVID-19: a randomized clinical trial
anticoagulant-triple-therapy.pdf
Study Details | Antiviral Clinical Trial for Long Covid-19 | ClinicalTrials.gov
RU2297846C2 - Method for treatment of focal and infiltrative pulmonary tuberculosis - Google Patents
Does Tenofovir Disoproxil Fumarate Mitigate COVID-19 Outcomes in Men with HIV?
Tenofovir and COVID: The Jury Is Still Out
Effect of Tenofovir Disoproxil Fumarate and Emtricitabine on nasopharyngeal SARS-CoV-2 viral load burden amongst outpatients with COVID-19: A pilot, randomized, open-label phase 2 trial
Tenofovir Disoproxil Fumarate Reduces the Severity of COVID-19 in Patients with Chronic Hepatitis B
Tenofovir-Containing Antiretroviral Therapy and Clinical Outcomes of SARS-CoV-2 Infection in People Living with HIV
Effects of entecavir and tenofovir disoproxil fumarate on the incidence and severity of COVID-19 in patients with chronic hepatitis B - BMC Infectious Diseases
Common HIV medication associated with improved COVID-19 outcomes
Dose matters: HIV drug could prevent coronaviruses, study finds